Manufacturer
NOVARTIS SINGAPORE PHARMACEUTICAL MANUFACTURING PTD. LTD.
Contents
Per 50mg FC tab Sacubitril 24.3 mg, valsartan 25.7 mg.
Indication
Heart failure (NYHA II-IV) in patient w/ reduced ejection fraction (LVEF ≤40%).
Instruction
May be taken with or without food.
Drug interaction
Aliskiren, ACE inhibitors, angiotensin receptor blocker, statins, sildenafil, lithium, K-sparing diuretics including mineral corticoid antagonist (eg, spironolactone, triamterene, amiloride); K supplements or K-containing salt substitutes, NSAIDs including selective COX-2 inhibitors, organic anion transporting polypeptide 1B1, 1B3, OAT3 (eg, rifampin, cyclosporine) or MPR2 (eg, ritonavir) inhibitors.
NOVARTIS SINGAPORE PHARMACEUTICAL MANUFACTURING PTD. LTD.
Contents
Per 50mg FC tab Sacubitril 24.3 mg, valsartan 25.7 mg.
Indication
Heart failure (NYHA II-IV) in patient w/ reduced ejection fraction (LVEF ≤40%).
Instruction
May be taken with or without food.
Drug interaction
Aliskiren, ACE inhibitors, angiotensin receptor blocker, statins, sildenafil, lithium, K-sparing diuretics including mineral corticoid antagonist (eg, spironolactone, triamterene, amiloride); K supplements or K-containing salt substitutes, NSAIDs including selective COX-2 inhibitors, organic anion transporting polypeptide 1B1, 1B3, OAT3 (eg, rifampin, cyclosporine) or MPR2 (eg, ritonavir) inhibitors.
Inquiry - Uperio 50mg Film-coated Tablets